Employee-Paid

As Congress scrutinizes the pharmacy benefit manager industry, on Wednesday, the Senate Finance and House Ways and Means committees advanced legislation that would regulate PBM's control over drug prices.

There's an urgent need to educate nonprofit employers about alternative benefit solutions to group health insurance, like qualified small employer health reimbursement arrangements (QSEHRAs) that may be a much better fit, according to a new report.

There's a 16.6% increase in the price of drugs in shortage, driven mostly by an increase in the price of generics, according to a new report.

The Federal Trade Commission changed course on previous statements opposing state legislation that would boost transparency over pharmacy benefit managers, as it carries out a sweeping investigation into the industry.

Opill's manufacturer, Perrigo, said it wants to make the pill "accessible and affordable" and it's still unclear if it can be covered by insurance, although advocates are pushing for the feds to make no-cost coverage without a prescription a requirement for all over-the-counter contraceptives.

The bill would require pharmacy benefit managers to submit detailed information to CMS each year that includes their interactions with the recommendation committees that decide on the drugs to be included in the formulary.